insights_auto
Why is TGTX down 3.19%?
Dive Deeperchevron_right
TGTX:NASDAQ
TG Therapeutics Inc common stock
$52.19
arrow_downward
-3.19%(-1.72) 1D
$51.90
arrow_downward
-0.56% (-0.29)todayPre-market
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$54.11
High
$54.11
Low
$51.34
Mkt. cap
8.04B
Avg. vol.
1.81M
Volume
498.00
P/E ratio
19.01
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.80
Shares outstanding
153.07M
No. of employees
399
Open
$54.11
High
$54.11
Low
$51.34
Mkt. cap
8.04B
Avg. vol.
1.81M
Volume
498.00
P/E ratio
19.01
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.80
Shares outstanding
153.07M
No. of employees
399
News stories
From web sources and news partners
Yahoo Finance
·
48 minutes ago
AST SpaceMobile (ASTS) Completed Its First Direct Satellite To Smartphone Test In Canada
Simply Wall Street
·
50 minutes ago
AI Chips Update - Transforming Video Into Actionable Insights With Pegasus 1.6
Proactive financial news
·
13 minutes ago
Jefferies maintains 'buy' rating on AstraZeneca ahead of third-quarter results
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorBiotechnology
Websitetgtherapeutics.com